Status:
TERMINATED
Innovative Central Line Securement Device in the Pediatric Population
Lead Sponsor:
Ryan St. Pierre-Hetz
Conditions:
Central Line Complication
Central Line Infection
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
This study involves evaluating pediatric patients with central lines to determine differences in line complications and quality of life in those with a novel central line securement device (wrap) as c...
Detailed Description
Children with central lines experience line breaks, line dislodgment's and line infections as a result of traditional securement techniques (dressings). These issues lead to the patients' increased he...
Eligibility Criteria
Inclusion
- Patients with a central line ages 0-18 years old who have never worn a wearable central line securement device (vest) will be eligible for the study.
Exclusion
- Those children who currently wear a central line securement device (vest)
- Children with central lines who are 19 years or older
- Those females with central lines and Tanner 2 breast or greater breast development as a wearable central line securement device (vest) will not fit properly to secure the central line and may increase the risk of the central line complications.
- If the patient does develop breast during the time of the study then the patient will no longer wear the wrap and will go back to securing their device in the traditional way. The investgators will still collect data on that patient and they will be evaluated in the device arm consistent with the intention to treat principle.
Key Trial Info
Start Date :
November 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04522778
Start Date
November 5 2020
End Date
May 1 2023
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224